Merck has announced 3 scientific efforts to combat #COVID19. The announcements include acquiring Themis, collaborating with IAVI to develop a vaccine & partnering with Ridgeback Bio to advance development of a novel antiviral candidate. Merck is another Rees customer working hard in the fight against the novel coronavirus.
For the latest information on Merck and their COVID-19 efforts visit https://www.mrknewsroom.com/news-release/research-and-development-news/merck-announce-multiple-scientific-efforts-combat-covid-1.
Rees provides continuous automated monitoring to a limitless number of applications in a wide range of industries. From Pharmaceutical to Blood Banking, Laboratory Animal Research to Biotech and Hospitals, Rees has become the standard by which other monitoring systems are judged.
This post is related to:
Personalized Wellness, Point-of-Care Services
